XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Stockholders Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock Par Value [Member]
Additional Paid-in Capital [Member]
Retained Earnings (Deficit) [Member]
Retained Earnings (Deficit) [Member]
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Dividends [Member]
Accumulated Other Comprehensive Income [Member]
Non-controlling Interest in Operating Partnership [Member]
Beginning balance at Dec. 31, 2018 $ 1,025,253   $ 608 $ 1,017,415 $ 12,831   $ (139,103) $ 2,412 $ 131,090
Beginning balance (Accounting Standards Update 2016-02) at Dec. 31, 2018   $ (34)       $ (34)      
Balance (in shares) at Dec. 31, 2018     60,849,206            
Stock based compensation 4,909     841         4,068
Grant of unvested restricted stock     89,961            
Dividends and distributions paid (81,894)           (71,657)   (10,237)
Redemption of common units to common stock     $ 4 5,824         (5,828)
Redemption of common units to common stock (in shares)     396,929            
Issuance of common stock, net 251,444   $ 135 251,309          
Issuance of common stock, net (in shares)     13,496,196            
Unrealized gain (loss) on interest rate swaps (8,061)             (7,102) (959)
Net income 8,224       7,207       1,017
Allocation of NCI in Operating Partnership       (18,069)         18,069
Balance at Dec. 31, 2019 1,199,841   $ 748 1,257,319 20,004   (210,760) (4,690) 137,220
Balance (in shares) at Dec. 31, 2019     74,832,292            
Stock based compensation 4,093     960         3,133
Grant of unvested restricted stock     21,930            
Dividends and distributions paid (91,748)           (80,892)   (10,856)
Redemption of common units to common stock     $ 2 3,605         (3,607)
Redemption of common units to common stock (in shares)     255,210            
Contribution of Property for common units 21,550               21,550
Issuance of common stock, net 160,191   $ 70 160,121          
Issuance of common stock, net (in shares)     6,996,824            
Unrealized gain (loss) on interest rate swaps (7,485)             (6,661) (824)
Net income 13,528       11,961       1,567
Allocation of NCI in Operating Partnership       2,783         (2,783)
Balance at Dec. 31, 2020 1,299,970   $ 821 1,424,787 31,965   (291,652) (11,351) 145,400
Balance (in shares) at Dec. 31, 2020     82,106,256            
Stock based compensation 5,050     833         4,217
Grant of unvested restricted stock     35,865            
Dividends and distributions paid (99,994)           (88,243)   (11,751)
Redemption of common units to common stock     $ 3 4,827         (4,830)
Redemption of common units to common stock (in shares)     343,515            
Contribution of Property for common units 20,791               20,791
Issuance of common stock, net 174,727   $ 77 174,650          
Issuance of common stock, net (in shares)     7,662,232            
Unrealized gain (loss) on interest rate swaps 7,080             6,279 801
Net income 33,957       30,058       3,899
Allocation of NCI in Operating Partnership       (385)         385
Balance at Dec. 31, 2021 $ 1,441,581   $ 901 $ 1,604,712 $ 62,023   $ (379,895) $ (5,072) $ 158,912
Balance (in shares) at Dec. 31, 2021     90,147,868